VistaGen Therapeutics, Inc. - stock earnings
VTGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -6.3 million USD | 411400 USD |
| 2023Q3 | -6.6 million USD | 277700 USD |
| 2023Q2 | -6.9 million USD | 177600 USD |
| 2023Q1 | -12.2 million USD | 175600 USD |
| 2022Q4 | -9.8 million USD | 179600 USD |
| 2022Q3 | -17.5 million USD | -892500 USD |
| 2022Q2 | -19.8 million USD | 310100 USD |
| 2022Q1 | -16.7 million USD | 38900 USD |
| 2021Q4 | -10.5 million USD | 357900 USD |
| 2021Q3 | -12.8 million USD | 358000 USD |
| 2021Q2 | -7.7 million USD | 354100 USD |
| 2021Q1 | -6.2 million USD | 441900 USD |
| 2020Q4 | -5.3 million USD | 313600 USD |
| 2020Q3 | -3.3 million USD | 334000 USD |
| 2020Q2 | -3.1 million USD | 334000 USD |
| 2020Q1 | -3.3 million USD | ? USD |
| 2019Q4 | -6.0 million USD | ? USD |
| 2019Q3 | -5.3 million USD | ? USD |
| 2019Q2 | -6.2 million USD | ? USD |
| 2019Q1 | -5.7 million USD | ? USD |
| 2018Q4 | -7.2 million USD | ? USD |
| 2018Q3 | -7.4 million USD | ? USD |
| 2018Q2 | -4.2 million USD | ? USD |
| 2018Q1 | -4.1 million USD | ? USD |
| 2017Q4 | -3.0 million USD | ? USD |
| 2017Q3 | -5.0 million USD | ? USD |
| 2017Q2 | -2.3 million USD | ? USD |
| 2017Q1 | -2.5 million USD | ? USD |
| 2016Q4 | -2.6 million USD | 1.3 million USD |
| 2016Q3 | -3.1 million USD | ? USD |
| 2016Q2 | -2.0 million USD | ? USD |
| 2016Q1 | -8.5 million USD | ? USD |
| 2015Q4 | -2.1 million USD | -2300 USD |
| 2015Q3 | -7.0 million USD | ? USD |
| 2015Q2 | -29.5 million USD | ? USD |
| 2015Q1 | -6.2 million USD | ? USD |
| 2014Q4 | -1.1 million USD | ? USD |
| 2014Q3 | -2.0 million USD | ? USD |
| 2014Q2 | -4.6 million USD | ? USD |
| 2014Q1 | -1.8 million USD | ? USD |
| 2013Q4 | 131000 USD | ? USD |
| 2013Q3 | -1.5 million USD | ? USD |
| 2013Q2 | -3.8 million USD | ? USD |
| 2013Q1 | -3.8 million USD | 200000 USD |
| 2012Q4 | -5.3 million USD | ? USD |
| 2012Q3 | -2.0 million USD | 200000 USD |
| 2012Q2 | -3.0 million USD | 468931 USD |
| 2012Q1 | -3.0 million USD | 468931 USD |
| 2011Q4 | -4.5 million USD | 2365 USD |
| 2011Q3 | -2.3 million USD | 316288 USD |
| 2011Q2 | -2.4 million USD | 554616 USD |
| 2011Q1 | -5325 USD | ? USD |
| 2010Q4 | -1942 USD | ? USD |
| 2010Q3 | -2123 USD | ? USD |
| 2010Q2 | -2107 USD | ? USD |
| 2010Q1 | -2804 USD | ? USD |
| 2009Q4 | -1407 USD | ? USD |
| 2009Q3 | -1293 USD | ? USD |
| 2009Q2 | -2079 USD | ? USD |
| 2009Q1 | -17219 USD | ? USD |
| 2008Q4 | -12977 USD | ? USD |
| 2008Q3 | -93 USD | ? USD |
| 2008Q2 | -3346 USD | ? USD |
| 2008Q1 | -2280 USD | ? USD |
| 2007Q4 | -4814 USD | ? USD |
| 2007Q3 | -3820 USD | ? USD |
| 2007Q2 | -2298 USD | ? USD |
| 2007Q1 | -2203 USD | ? USD |
VTGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.2 million USD | -227300 USD |
| 2022 | -47.8 million USD | 1.1 million USD |
| 2021 | -17.9 million USD | 1.1 million USD |
| 2020 | -20.8 million USD | 334000 USD |
| 2019 | -24.6 million USD | ? USD |
| 2018 | -14.3 million USD | ? USD |
| 2017 | -10.3 million USD | 1.3 million USD |
| 2016 | -47.2 million USD | ? USD |
| 2015 | -13.9 million USD | -135000 USD |
| 2014 | -3.0 million USD | ? USD |
| 2013 | -12.9 million USD | 200400 USD |
| 2012 | -12.2 million USD | 1.3 million USD |
| 2011 | -8976 USD | ? USD |
| 2010 | -21998 USD | ? USD |
| 2009 | -16416 USD | ? USD |
| 2008 | -4754 USD | ? USD |
VTGN
Price: $4.50
52 week price:
Earnings Per Share: -2.96 USD
P/E Ratio: -1.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 11.3 million
Ebitda: -2.8 millionMarket Capitalization: 136.2 million